GE Selling Biopharma Unit in $21.4 Billion Deal
Credit to Author: Darrell Proctor| Date: Mon, 25 Feb 2019 21:32:59 +0000
General Electric’s (GE’s) sale of its biopharma unit on February 25 is designed to reduce the company’s overall debt load, and CEO Larry Culp said the deal is the latest step in his plan to strengthen the whole of GE, particularly the company’s struggling Power division. GE on Monday agreed to sell the biopharma part […]
The post GE Selling Biopharma Unit in $21.4 Billion Deal appeared first on POWER Magazine.
Read more